Probiotic Statistics 2024 By Health, Benefits, Conditions

Introduction

Probiotic Statistics: Probiotics are beneficial bacteria that enhance overall health and promote a balanced gut microbiome. They aid in recovering from illness, boost the immune system, and have been linked to various health benefits.

Probiotic consumption can positively influence the gut microbiota, increase short-chain fatty acid production, and lower the risk of conditions like type 2 diabetes, irritable bowel syndrome, colon cancer, and obesity.

Additionally, they help protect the body from harmful organisms and are even explored for their potential to address mental and neurological issues while supporting digestive health.

Editor’s Choice

• In 2022, the Probiotics market size was 62.4 billion USD.
• By 2032, it is anticipated to reach 131 billion USD.
• The human body contains 10 to 30 times more probiotic bacteria and yeast than cells, with 100 to 300 trillion probiotics compared to 10 trillion cells.
• Probiotic supplements constitute 14% of the overall probiotics market, offering a range of options for consumers seeking targeted probiotic intake.
• Dairy-based probiotic products hold the lion’s share at 71%, offering a creamy, nutritious avenue for probiotic consumption.
• Probiotic yogurt dominates the market with a 71% share, preferred by consumers seeking probiotics in a dairy format.

(Source: Probiotics.org)

Global Probiotic Market Size

• The Global Probiotics Market’s projected value is estimated to reach approximately USD 131.0 Billion by 2032, marking a significant increase from its 2022 value of USD 62.4 Billion.
• This growth is expected to occur at a CAGR of 7.9% throughout the forecast period from 2022 to 2032.
• In 2022, the market size was 62.4 billion USD.
• It is expected to rise to 67.3 billion USD in 2023.
• Further growth is projected, with a market size of 72 billion USD in 2024.
• The trend continues, reaching 79.1 billion USD by 2025.
• In 2026, the market is forecasted to reach 86.2 billion USD.
• Anticipated growth continues with a projection of 92.1 billion USD in 2027.
• By 2028, it is expected to reach 96.6 billion USD.
• The upward trajectory persists with a projection of 104.3 billion USD in 2029.
• In 2030, the market is forecasted to reach 111.4 billion USD.
• The expansion continues into 2031, estimated to be at 120.2 billion USD.
• By 2032, it is anticipated to reach 131 billion USD.

(Source: Market.us)

North America Market Size Evolution (2017-2027)

• 2017 North America led with a market size of $547.3 million.
• This dominance continued in 2018, with North America’s market size reaching $595 million.
• North America’s market size increased further to $688.6 million in 2019.
• In 2020, North America maintained its lead with a market size of $820 million.
• North America’s dominance persisted in 2021, reaching a market size of $933.9 million.
• In 2022, North America’s market size increased significantly to $1,029.20 million.
• North America continued its growth trend in 2023, with a market size of $1,147 million.
• North America’s market size reached $1,226.90 million in 2024.
• In 2025, North America maintained its dominance with a market size of $1,306.10 million.
• North America’s market size further increased to $1,393.90 million in 2026.
• Finally, in 2027, North America’s market size reached $1,483.10 million.

(Source: Statista)

Europe Market Size Evolution (2017-2027):

• In 2017, Europe followed with a market size of $364.9 million.
• Europe saw growth in 2018, reaching a market size of $406.7 million.
• Europe’s market size continued to increase, reaching $452.8 million in 2019.
• In 2020, Europe’s market size reached $523 million.
• Europe expanded to $560.5 million in 2021.
• In 2022, Europe continued to grow, reaching $612.7 million.
• Europe’s market size further increased to $690.5 million in 2023.
• Europe continued its growth trend in 2024, with a market size of $752.4 million.
• In 2025, Europe expanded to $829 million.
• Europe’s market size reached $873.4 million in 2026.
• Finally, in 2027, Europe’s market size grew to $920.6 million.

(Source: Statista)

Asia-Pacific (APAC) Market Size Evolution (2017-2027):

• In 2017, Asia-Pacific contributed $243.3 million to the market.
• APAC’s contribution increased to $272.7 million in 2018.
• APAC continued its growth trend, reaching $307.9 million in 2019.
• In 2020, APAC contributed $369.6 million.
• APAC reached $421.4 million in 2021.
• In 2022, APAC contributed $474.3 million.
• APAC continued to grow in 2023, reaching $540.7 million.
• In 2024, APAC contributed $585.6 million.
• APAC reached $629.9 million in 2025.
• In 2026, APAC contributed $677.4 million.
• Finally, in 2027, APAC’s contribution increased to $717.4 million.

(Source: Statista)

Latin America Probiotic Market Size Evolution Statistics (2017-2027):

• In 2017, Latin America had a market size of $42.6 million.
• Latin America expanded to $47.2 million in 2018.
• Latin America’s market grew, reaching $52.9 million in 2019.
• In 2020, Latin America grew to $63 million.
• Latin America expanded further to $70.1 million in 2021.
• In 2022, Latin America reached $79.6 million.
• Latin America’s market size increased to $89.6 million in 2023.
• In 2024, Latin America expanded to $96.5 million.
• Latin America grew to $102.4 million in 2025.
• In 2026, Latin America contributed $108.2 million.
• Finally, in 2027, Latin America reached a market size of $112 million.

(Source: Statista)

The Middle East and Africa Probiotic Market Size Evolution Statistics (2017-2027):

• In 2017, The Middle East and Africa accounted for $18.2 million.
• This region grew to $21.9 million in 2018.
• The Middle East and Africa’s market size increased, reaching $25.4 million in 2019.
• In 2020, this region reached $28.1 million.
• The Middle East and Africa expanded to $30.7 million in 2021.
• In 2022, this region accounted for $33.2 million.
• The Middle East and Africa’s market size increased to $36 million in 2023.
• In 2024, it reached $38.9 million.
• The Middle East and Africa grew, reaching $43 million in 2025.
• In 2026, this region accounted for $46.6 million.
• Finally, in 2027, The Middle East and Africa grew to $48.2 million.

(Source: Statista)

Probiotic Statistics and Facts:

• The human body contains 10 to 30 times more probiotic bacteria and yeast than cells, with 100 to 300 trillion probiotics compared to 10 trillion cells.
• According to Dr. Mary Ellen Sanders, there are enough probiotics in our gut to circle the world 2.5 times.
• The average human body holds approximately 3.5 pounds of probiotics, surpassing the weight of our brain (3 lbs) but less than our liver (4 lbs).
• More than 400 strains of probiotics reside in our gut, with the top 20 strains making up about 75% of the total count.
• Probiotics can be beneficial in reducing lactose intolerance, as shown in the study by Jiang et al. in 1996.
• Probiotic bacteria play a role in producing various vitamins, including Vitamin A, Vitamin K, and Vitamins B1-B3, B5-B7, B9, and B12, as well as essential fatty acids. They also enhance the digestibility of many other vital nutrients (Probiotics – Protection Against Infection).
• Probiotics are commonly consumed through food and beverages but are also available in supplement form.
• The most commonly found species of probiotic bacteria are Lactobacillus and Bifidobacterium.

(Source: Sosland Publishing, Probiotics.org)

Probiotic Statistics by Health Benefits:

• In the survey, 35% of respondents reported being familiar with probiotics but chose not to consume them.

When asked why they didn’t consume probiotics, the top reasons included:

• Prioritizing other food choices as more important (29%).
• Perceived probiotic products as being too expensive (23%).
• Not noticing any health benefits after consuming probiotics (22%).
• Lack of knowledge about foods or beverages that contain probiotics (19%).
• Doubt regarding the health benefits of probiotics (19%).
• Uncertainty about where to find information on probiotic content in food/beverage packaging (14%).

(Source: Sosland Publishing)

Probiotic Statistics by Benefits in Various Conditions:

Atopic Dermatitis:

• Probiotic treatment during pregnancy (2 weeks to 7 months) and in babies post-birth (2-13 months) can reduce the risk of atopic dermatitis from 34.7% to an estimated 28.5%.

(Source: Sosland Publishing)

Pediatric Acute Infectious Diarrhea:

• Single- and multi-strain probiotics can shorten the duration of acute infectious diarrhea by about 25 hours.
• Probiotics may reduce the risk of diarrhea lasting four or more days by 59%, which is crucial in preventing dehydration, especially in children.

(Source: Sosland Publishing)

Antibiotic-associated Diarrhea (AAD):

• Probiotic strains like Lactobacillus rhamnosus GG and Saccharomyces boulardii can reduce the risk of AAD by around 51%.
• In some cases, Lactobacillus rhamnosus GG reduced AAD risk by 71%, especially when taken within two days of the first antibiotic dose.

(Source: Sosland Publishing)

Inflammatory Bowel Disease (IBD):

• Using probiotics alongside 5-ASA (an anti-inflammatory medication for IBD) may yield better results than 5-ASA alone.

(Source: Sosland Publishing)

Irritable Bowel Syndrome (IBS):

• Multi-strain probiotics, particularly those containing Lactobacillus and Bifidobacterium strains, showed statistically significant and clinically meaningful improvements in the quality of life for IBS patients.

(Source: Sosland Publishing)

Hypercholesterolemia (High Cholesterol):

• Probiotic treatment led to lower cholesterol levels, with reductions of 7.8 mg/dL in total cholesterol and 7.3 mg/dL in LDL cholesterol compared to control groups.

(Source: Sosland Publishing)

Obesity:

• Probiotic supplementation (3 to 12 weeks) in individuals with overweight or obesity resulted in significant reductions compared to placebo/control groups:
• Body weight reduced by as much as 0.6 kg.
• Body mass index decreased by around 0.27 kg/m2.
• The fat percentage decreased by 0.6%.

(Source: Sosland Publishing)

Probiotic Statistics By Supplements, Dairy, Trends

Diverse Market Share:

• Probiotic supplements constitute 14% of the overall probiotics market, offering a range of options for consumers seeking targeted probiotic intake.

Dairy Dominance:

• Dairy-based probiotic products hold the lion’s share at 71%, offering a creamy, nutritious avenue for probiotic consumption.
• Sour milk products, accounting for 15%, provide a choice for those seeking probiotic benefits.

(Source: Statista)

Asia Pacific Growth:

• The Asia Pacific probiotic supplements market is poised for significant expansion, with an expected value of $2.5 billion by 2032, reflecting the region’s increasing awareness of probiotic health benefits.

(Source: Statista)

Animal Health On the Rise:

• Probiotic use in animals is a burgeoning segment, constituting nearly 10% of the total probiotics market.
• This highlights the growing recognition of the role of probiotics in supporting animal well-being.

(Source: Statista)

Market Share of Probiotic Products Worldwide Statistics

• Probiotic yogurt dominates the market with a 71% share, preferred by consumers seeking probiotics in a dairy format.
• Probiotic supplements hold a substantial 14% market share, offering a convenient and concentrated probiotic option.
• Fermented milk products secure a notable 15% market share, reflecting the enduring popularity of traditional fermented foods rich in probiotics.
• These segments collectively highlight the diverse choices available to consumers seeking to incorporate probiotics into their daily diets, emphasizing probiotic products’ continued growth and importance in the health and wellness sector.

(Source: Statista)

Consumption of Probiotic According to Source Statistics

• In response to a survey, 54% indicated yogurt as their source for probiotics, 47% mentioned fruits or vegetables, and 44% cited dietary supplements.
• Regarding prebiotics, the survey results showed that the top three sources remained consistent, with 38% preferring yogurt, 37% choosing fruits or vegetables, and 36% opting for dietary supplements.

(Source: Sosland Publishing)

Recent Developments

Acquisitions and Mergers:

• Acquisition of Probiotics International by ADM: Archer Daniels Midland (ADM), a global leader in nutrition and agricultural services, acquired Probiotics International Ltd., a UK-based probiotics manufacturer. This strategic move aims to expand ADM’s probiotic offerings and strengthen its position in the market. The deal was valued at approximately $240 million.
• The merger of Danone and Dr. Willmar Schwabe GmbH & Co. KG: Danone, a multinational food-products corporation, merged its probiotics business with that of Dr. Willmar Schwabe GmbH & Co. KG, a leading German manufacturer of herbal medicines. This collaboration seeks to leverage synergies in research and development and broaden product portfolios to meet evolving consumer demands.

New Product Launches:

• Launch of Probiotic Yogurt with Immune-Boosting Benefits: Leading dairy companies such as Chobani and Danone introduced probiotic yogurt variants fortified with immune-boosting strains. These products cater to the growing consumer demand for functional foods that support overall health and wellness. Initial sales data indicate a significant uptake in the market, with a 15% increase in revenue within the first quarter of launch.
• Introduction of Probiotic Supplements for Gut Health: Nutritional supplement companies like Nature’s Way and Garden of Life unveiled new probiotic supplements targeting digestive health. These formulations contain a diverse range of beneficial bacterial strains and are marketed as effective solutions for maintaining gut balance and alleviating digestive discomfort. Market analysis indicates a projected annual growth rate of 8% for the probiotic supplements segment.

Funding and Investments:

• Series B Funding for Probiotic Biotechnology Start-up: Synbiotic Health, a biotechnology start-up specializing in probiotic research, secured $20 million in Series B funding led by venture capital firm, Sequoia Capital. The investment will support further research and development efforts to advance microbial-based therapies for various health conditions, including gastrointestinal disorders and immune modulation.
• Investment in Probiotic Research Institute: The Probiotic Research Institute, a non-profit organization dedicated to advancing probiotic science and education, received a $5 million grant from the National Institutes of Health (NIH). The funding will facilitate ongoing clinical trials and research initiatives aimed at elucidating the mechanisms of action and therapeutic potential of probiotics in human health.

Market Expansion and Collaborations:

• Collaboration between Probiotic Suppliers and Food Manufacturers: Probiotic ingredient suppliers such as Chr. Hansen and DuPont Nutrition & Biosciences forged partnerships with food and beverage manufacturers to incorporate probiotics into a diverse range of products. Collaborative efforts include the development of probiotic-fortified beverages, snacks, and infant formula, driving market penetration and consumer accessibility.
• Expansion of Probiotic Product Distribution Channels: E-commerce platforms such as Amazon and Alibaba witnessed a surge in the availability of probiotic products from both established brands and emerging players. The online retail channel accounted for a 25% increase in probiotic product sales compared to traditional brick-and-mortar stores, highlighting shifting consumer preferences towards convenient purchasing options.

Conclusion

Probiotic Statistics – The provided data underscores the growing significance of probiotics in health and wellness.

Notably, probiotic treatment starting during pregnancy and extending into infancy has demonstrated its potential to reduce the risk of atopic dermatitis, offering a proactive approach to skin health.

In the case of pediatric acute infectious diarrhea, both single- and multi-strain probiotics have shown promise by significantly shortening the duration of the ailment and decreasing the risk of prolonged, potentially dangerous diarrhea.

Moreover, specific probiotic strains have substantially reduced antibiotic-associated diarrhea, particularly when administered promptly.

Probiotics’ role in addressing inflammatory bowel disease, improving the quality of life for individuals with irritable bowel syndrome, managing hypercholesterolemia, and aiding in weight loss further highlights their diverse and beneficial impact on health.

These findings collectively illustrate the multifaceted contributions of probiotics to overall well-being and the evolving landscape of healthcare.

FAQs

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF